Single-cell RNA Sequencing Identifies Prognostic Biomarkers in Extramedullary Multiple Myeloma
Our study has proposed a risk score model based on seven identified signature genes for MM prognosis and revealed CD4+ T cells to be a major immune cell type associated with MM progression, contributing to personalized treatment decision-making and precise risk stratification of MM.
Authors
- Menghan Yang (ORCID: https://orcid.org/0000-0003-0764-1946)
- Fan Yu (ORCID: https://orcid.org/0000-0002-6001-2121)
- Hui Qin (ORCID: https://orcid.org/0000-0002-2242-8257)
Institutions
- Shanghai Jiao Tong University (CN)
- Anhui Medical University (CN)
- Shanghai First People's Hospital (CN)
- Second Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-05-06
- DOI
- https://doi.org/10.2174/0109298673352012250414100227
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00